Ngoc-Tuyen Truong

Prof. Ngoc-Tuyen Truong


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2022 in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
EPEm Canh Pham
Em Canh Pham
NTNgoc-Tuyen Truong
Ngoc-Tuyen Truong
NDNguyen Hanh Dong
Nguyen Hanh Dong
DVDuy Duc Vo
Duy Duc Vo
TDTuoi Thi Hong Do
Tuoi Thi Hong Do
Background: Many compounds containing a five-membered heterocyclic ring display exceptional chemical properties and versatile biological activities. Objective: The objective of the present study was to prepare the 5-substituted 2-amino-1,3,4- oxadiazole and 2-amino-1,3,4-thiadiazole derivatives and evaluate their potential anticancer, antibacterial and antifungal activities. Methods: Twenty-seven derivatives were synthesized by iodine-mediated cyclization of semicarbazones or thiosemicarbazones obtained from condensation of semicarbazide or thiosemicarbazide and aldehydes. The structures were confirmed by 1H-NMR, 13C-NMR and MS spectra. The antibacterial and antifungal activities were evaluated by diffusion method and the anticancer activities were evaluated by MTT assay. Results: Twenty-seven derivatives have been synthesized in moderate to good yields. A number of derivatives exhibited potential antibacterial, antifungal and anticancer activities. Conclusion: Compounds (1b, 1e and 1g) showed antibacterial activity against Streptococcus faecalis, MSSA and MRSA with MIC value ranging between 4 to 64 μg/mL. Compound (2g) showed antifungal activity against Candida albicans (8 μg/mL) and Aspergillus niger (64 μg/mL). Compound (1o) exhibited high cytotoxic activity against HepG2 cell line (IC50 value 8.6 μM) which is comparable to the activity of paclitaxel, and is non-toxic on LLC-PK1 normal cell line. The structure activity relationship and molecular docking study of the synthesized compounds have also been reported.

19 December 2022 in RSC Advances
Verified
Journal Article
Open access
PDF file
EPEm Canh Pham
Em Canh Pham
TTTuong Vi Le Thi
Tuong Vi Le Thi
HHHuong Ha Ly Hong
Huong Ha Ly Hong
BTBich Ngoc Vo Thi
Bich Ngoc Vo Thi
LVLong Binh VONG
Long Binh VONG
NTNgoc-Tuyen Truong
Ngoc-Tuyen Truong
The purpose of this study is to synthesize novel N ,2,6-trisubstituted 1 H -benzimidazole derivatives and evaluation of their antibacterial, antifungal, and anticancer activities as well as to study their mechanism of action.

21 July 2022 in RSC Advances
Verified
Journal Article
Open access
PDF file
EPEm Canh Pham
Em Canh Pham
TLTuong Vi Thi Le
Tuong Vi Thi Le
NTNgoc-Tuyen Truong
Ngoc-Tuyen Truong
The purpose of this study is to synthesize novel N-substituted 6-(chloro/nitro)-1H-benzimidazole derivatives with various substituted aryl groups at position 2 and alkylation at position 1, and evaluate their antimicrobial and anticancer activities.

16 September 2022 in ACS Omega
Verified
Journal Article
Open access
NDNam Q. H. Doan
Nam Q. H. Doan
NNNgan T. K. Nguyen
Ngan T. K. Nguyen
VDVu B. Duong
Vu B. Duong
HNHa T. T. Nguyen
Ha T. T. Nguyen
LVLong Binh VONG
Long Binh VONG
NTNgoc-Tuyen Truong
Ngoc-Tuyen Truong
Addressing the growing burden of cancer and the shortcomings of chemotherapy in cancer treatment are the current research goals. Research to overcome the limitations of curcumin and to improve its anticancer activity via its heterocycle-fused monocarbonyl analogues (MACs) has immense potential. In this study, 32 asymmetric MACs fused with 1-aryl-1H-pyrazole (7a-10h) were synthesized and characterized to develop new curcumin analogues. Subsequently, via initial screening for cytotoxic activity, nine compounds exhibited potential growth inhibition against MDA-MB-231 (IC50 2.43-7.84 μM) and HepG2 (IC50 4.98-14.65 μM), in which seven compounds showing higher selectivities on two cancer cell lines than the noncancerous LLC-PK1 were selected for cell-free in vitro screening for effects on microtubule assembly activity. Among those, compounds 7d, 7h, and 10c showed effective inhibitions of microtubule assembly at 20.0 μM (40.76-52.03%), indicating that they could act as microtubule-destabilizing agents. From the screening results, three most potential compounds, 7d, 7h, and 10c, were selected for further evaluation of cellular effects on breast cancer MDA-MB-231 cells. The apoptosis-inducing study indicated that these three compounds could cause morphological changes at 1.0 μM and could enhance caspase-3 activity (1.33-1.57 times) at 10.0 μM in MDA-MB-231 cells, confirming their apoptosis-inducing activities. Additionally, in cell cycle analysis, compounds 7d and 7h at 2.5 μM and 10c at 5.0 μM also arrested MDA-MB-231 cells in the G2/M phase. Finally, the results from in silico studies revealed that the predicted absorption, distribution, metabolism, excretion, and the toxicity (ADMET) profile of the most potent MACs might have several advantages in addition to potential disadvantages, and compound 7h could bind into (ΔG -10.08 kcal·mol-1) and access wider space at the colchicine-binding site (CBS) than that of colchicine or nocodazole via molecular docking studies. In conclusion, our study serves as a basis for the design of promising synthetic compounds as anticancer agents in the future.

9 September 2022 in ACS Omega
Verified
Journal Article
Open access
EPEm Canh Pham
Em Canh Pham
NTNgoc-Tuyen Truong
Ngoc-Tuyen Truong
Naphthamide is a common structural framework with diverse pharmacological activities. Ten novel 2-naphthamide derivatives have been designed, synthesized, and evaluated for their in vitro antibacterial, antifungal, and anticancer activities. The title compounds were synthesized from dimethoxybenzaldehyde derivatives through a four-step microwave-assisted synthesis process. The structures were confirmed by 1H NMR, 13C NMR, and MS spectra. Compound 8b showed good antibacterial activity against Escherichia coli, Streptococcus faecalis, Salmonella enterica, MSSA, and MRSA with MIC values of 16, 16, 16, 8, and 16 μg/mL, respectively, compared to ciprofloxacin (MIC = 8-16 μg/mL). Compounds 5b (IC50 = 3.59-8.38 μM) and 8b (IC50 = 2.97-7.12 μM) exhibited good cytotoxic activity against C26, HepG2, and MCF7 cancer cell lines as compared to paclitaxel (IC50 = 2.85-5.75 μM). Moreover, compounds 5b and 8b exhibited better anticancer activity than PTX against the C26 cell line. In particular, compound 8b showed potent in vitro VEGFR-2 inhibitory activity with the IC50 value of 0.384 μM compared with sorafenib (IC50 = 0.069 μM). Therefore, compound 8b is the most potent compound for anticancer activity as indicated by in vitro cell line inhibition, in silico ADMET, molecular docking, and in vitro VEGFR-2 inhibition studies.

16 June 2023 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
NDNam Q.H. Doan
Nam Q.H. Doan
NNNgan T.K. Nguyen
Ngan T.K. Nguyen
NNNgoc B. Nguyen
Ngoc B. Nguyen
TTThi T. Tran
Thi T. Tran
QTQuang N. Tran
Quang N. Tran
NTNgoc-Tuyen Truong
Ngoc-Tuyen Truong